Transcatheter Valve Replacement: Risk Levels and Contemporary Outcomes

Manuel Reyes; Michael J Reardon

doi:10.14797/mdcj-13-3-126

Transcatheter Valve Replacement: Risk Levels and Contemporary Outcomes

Methodist Debakey Cardiovasc J. 2017 Jul-Sep;13(3):126-131. doi: 10.14797/mdcj-13-3-126.

Authors

Manuel Reyes¹, Michael J Reardon¹

Affiliation

¹ HOUSTON METHODIST DEBAKEY HEART & VASCULAR CENTER, HOUSTON METHODIST HOSPITAL, HOUSTON, TEXAS.

Abstract

Transcatheter aortic valve replacement (TAVR) has exploded into medical care for aortic stenosis, thus changing the treatment options for patients. TAVR is currently approved for extreme-risk, high-risk, and intermediate-risk patients with symptomatic severe aortic stenosis, and randomized trials for low-risk patients are underway. This article traces the trajectory of TAVR as a viable option for higher-risk patients and examines current outcomes.

Keywords: SAVR; TAVR; expandable valve; surgical aortic valve replacement; transcatheter aortic valve replacement.

Publication types

Review

MeSH terms

Aortic Valve / diagnostic imaging
Aortic Valve / physiopathology
Aortic Valve / surgery*
Aortic Valve Stenosis / diagnostic imaging
Aortic Valve Stenosis / mortality
Aortic Valve Stenosis / physiopathology
Aortic Valve Stenosis / surgery*
Clinical Decision-Making
Heart Valve Prosthesis
Humans
Patient Selection
Prosthesis Failure
Recovery of Function
Risk Assessment
Risk Factors
Transcatheter Aortic Valve Replacement* / adverse effects
Transcatheter Aortic Valve Replacement* / instrumentation
Transcatheter Aortic Valve Replacement* / mortality
Treatment Outcome